Skip to content
Prudent Biotech
  • BLOG
    HOME
  • SYSTEMATIC
    INVESTING
  • NEWSLETTERS
    • Prudent BIOTECH
    • Prudent SMALL CAP
    • Prudent HEALTHCARE
  • MORE
    • FAQ
    • CONTACT US
  • LOGIN
    • LOGIN – BIOTECH
    • LOGIN – SMALL CAP
  • SIGN UP
    • SIGN UP – BIOTECH
    • RENEWAL – BIOTECH
is_archive

Healthcare Stocks
June 13, 2023

Akero Therapeutics: Marching On And Delivering Promising Results

Akero Therapeutics is making strong progress in developing a treatment for NASH, an area of high unmet medical need.The company's lead product candidate has shown promising and highly significant results
by Chandra
Prudent Biotech

© 2024. All Rights Reserved.